you are viewing a single comment's thread.
Bioinvestor makes very good point. Loss of Allegra royalties would be very bad for AMRI. And it's a challenging time for pharmas and biotechs. I'm simply optimistic about the future, that management will overcome the challenges. That the current short term challenges present long term opportunities. There are many uncertainties about the problems and opportunities. I choose to be optimistic.